- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Merck's Ebola Vaccine Trial Halted
Reuters has reported that Merck's Ebola vaccine trial has been temporarily halted.
A clinical trial of the Ebola vaccine by Merck and NewLink has been interrupted in all 59 volunteers in Geneva a week early "as a measure of precaution" after 4 patients complained of joint pains in hands and feet, the University of Geneva Hospital said on Thursday.
"They are all fine and being monitored regularly by the medical team leading the study," the hospital said in a statement.
The human safety trials are due to resume on January 5 in up to 15 volunteers after checks to ensure that the joint pain symptoms were "benign and temporary," the hospital said.
Original report by Reuters: http://tmsnrt.rs/1wguI96
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
